BioXcel Appoints Dr. Peter Mueller as Chairman of Scientific Advisory Board

BRANFORD, Conn., Oct. 12, 2016 (GLOBE NEWSWIRE) — BioXcel, a privately held biopharmaceutical company based in Connecticut, today announced the appointment of Dr. Peter Mueller, Ph.D. as Chairman of its Scientific Advisory Board (“SAB”), which will serve as a strategic resource to the Company as it advances its clinical pipeline of immuno-oncology and neuroscience candidates.”We are thrilled to have Dr. Mueller join BioXcel as the Chairman of our Scientific Advisory Board. He has tremendous expertise in drug discovery and development, which we believe will be valuable in shaping the strategic direction of the Company. We look forward to gaining counsel from Dr. Mueller on the assessment of various scientific and clinical opportunities as well as ongoing development of our pipeline programs.  We plan to further expand our SAB to include…


Link to Full Article: BioXcel Appoints Dr. Peter Mueller as Chairman of Scientific Advisory Board